Thermo Fisher Scientific Ion S5

Ion S5 is a benchtop next-generation sequencing (NGS) system introduced by Thermo Fisher Scientific in September 2015. Designed to simplify targeted sequencing workflows, this instrument leverages semiconductor sequencing technology to deliver rapid and cost-effective results. Its versatility makes it suitable for a wide range of applications, from microbial genome analysis to comprehensive exome and transcriptome studies.

Key features:

• Scalability: Compatible with multiple Ion chips (520, 530, and 540), allowing outputs from 5 million to 80 million reads per run, catering to various project sizes.

• Speed: Achieves sequencing run times as short as 2.5 hours, enabling a complete workflow from DNA library preparation to data analysis in approximately 24 hours when paired with the Ion Chef System.

• Simplicity: Features cartridge-based, plug-and-play reagents and a user-friendly interface, reducing setup time to about 15 minutes per run.

• Low Sample Input Requirement: Capable of processing challenging samples with as little as 1 ng of input DNA or RNA, including formalin-fixed paraffin-embedded (FFPE) tissues and cell-free DNA.

Applications:

• Oncology Research: Facilitates targeted sequencing of cancer-related gene panels, aiding in the identification of genetic mutations and biomarkers.

• Infectious Disease Studies: Enables rapid sequencing of microbial genomes for pathogen identification and epidemiological tracking.

• Genetic Disease Research: Supports exome and transcriptome sequencing to uncover genetic variants associated with inherited disorders.

• Biotechnology: Essential for applications such as gene editing, synthetic biology, and molecular diagnostics, providing high-throughput sequencing capabilities critical for biopharmaceutical development and biomanufacturing processes.

Commonly used in:

• Academic Research Laboratories: For conducting fundamental studies in genetics, molecular biology, and biotechnology.

• Clinical Research Facilities: To advance translational research and develop personalized medicine approaches.

• Biotechnology Companies: For applications in bioprocessing, gene editing, and synthetic biology, supporting the development of novel therapeutics and diagnostics.

Since its release in 2015, the Ion S5 system has been widely adopted in various research settings, offering a balance of speed, simplicity, and scalability that continues to meet the evolving demands of the scientific community.